For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com  Inclusion Criteria:  Self-reported medical diagnosis of stage II or stage III melanoma Have been resected (had surgery) for their melanoma within 12 months prior to study participation  Exclusion Criteria:  Self-reported stage IIa Self-reported recurrence of melanoma after surgery  Other protocol-defined inclusion/exclusion criteria apply